• {%brandMenuItems%}
    • {%itemName%} {%arrowSpan%}
    • {%itemName%} {%arrowSpan%}
    • {%selfProduct%}
      • {%languages%}
    • This website is for UK Healthcare Professionals only

      FRONTIERS promotional meetings are fully funded and organised by AbbVie.

      On demand: Access content from previous meetings

      November 8th 2021

      Frontiers was a one-day, CPD-accredited in-person meeting for UK HCPs involved in the management of patients with CLL. Live presentations and broadcasts from a London hub to seven regional meeting spokes, an expert faculty of speakers and regional chairs, coupled with a real-time audience-interactive tool, ensured high-quality content and unique networking opportunities. We invite you to view key presentations from FRONTIERS 2021.

      Dr Renata Walewska

      Back to the future

      Scene-setting overview reflecting the themes of the day

      Prof Paul Moss

      Vexing questions:
      What to Rx when we need to Vx

      COVID-19, vaccination and CLL

      Prof Paul Moss and Dr Renata Walewska

      COVID-19, vaccination and CLL

      Addressing questions

      Dr Othman Al-Sawaf


      Redefining outcomes for patients with CLL, the importance of achieving a deep response

      Dr Talha Munir

      Points of practice

      Practical management advice when treating with Venclyxto®▼ (venetoclax)

      Dr Dima El-Sharkawi 

      We’re in this together:

      Case study (first-line management of CLL)

      Dr Piers Patten  

      We’re in this together:

      Case study (management of R/R CLL)

      LIVE: Register and join us for future events


      Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk.

      Adverse events should also be reported to AbbVie on GBPV@abbvie.com

      UK-VNCCLL-210586. Date of preparation: January 2022.